Bumetanide Tablet
Product Images NDC 0615-8616

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 0615-8616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structural Formula (Bumetanide 8614 8615 8616 1)

Chemical Structural Formula (Bumetanide 8614 8615 8616 1)
Chemical structure of the active ingredient Bumetanide, displaying its molecular composition with key functional groups including a carboxyl group, sulfonamide, and other substituents characteristic of the compound.*
FDA Label Image

Principal Display Panel (Bumetanide 8614 8615 8616 2)

Principal Display Panel (Bumetanide 8614 8615 8616 2)
Label panel for Bumetanide Tablets USP 0.5 mg by NCS HealthCare of KY, LLC dba Vangard Labs. The label shows a quantity of 30 tablets, with lot number 8614 and spaces for lot and expiration date. Directions indicate storage temperatures and institutional use only. The label includes multiple small barcode stickers for individual tablets and a medication administration record grid for daily dosing.*
FDA Label Image

Principal Display Panel (Bumetanide 8614 8615 8616 3)

Principal Display Panel (Bumetanide 8614 8615 8616 3)
Bumetanide Tablets, USP 1 mg oral dosage form medication label. The label includes the proprietary and generic name Bumetanide, strength of 1 mg, quantity of 30 tablets, and specifies Rx only. The labeler is NCS HealthCare of KY, LLC dba Vangard Labs, packaged by Vangard in Glasgow, KY. The label also provides storage instructions and a calendar with barcode stickers for lot number 8615.*
FDA Label Image

Principal Display Panel (Bumetanide 8614 8615 8616 4)

Principal Display Panel (Bumetanide 8614 8615 8616 4)
Bumetanide Tablets, USP 2 mg, oral tablets packaged by Vangard Labs for Advagen. The label shows the product name, dosage strength, quantity of 30 tablets, lot number 8616, multiple barcodes, storage instructions between 20°C to 25°C, and a section for received dates. The label indicates institutional use only and includes manufacturer information from Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.